The New Jersey Economic Development Authority (NJEDA) approved 161 applications for investments into 32 emerging technology life sciences companies through the state’s Angel Investor Tax Credit Program in 2019. This represents the injection of $33.1 million in private capital into the state’s innovation ecosystem. More than 120 of the applications, totaling nearly $22 million in investments, were approved in the fourth quarter of the year alone. Please read more here.